Predictive factors improving survival after gastric and hepatic surgical treatment in gastric cancer patients with synchronous liver metastases

被引:0
|
作者
LIU Jing [1 ,2 ]
LI Jing-hui [1 ]
ZHAI Ru-jun [1 ]
WEI Bo [1 ]
SHAO Ming-zhe [1 ]
CHEN Lin [1 ]
机构
[1] Department of General Surgery,Chinese People's Liberation Army General Hospital
[2] Breast Cancer Surgical Department,Tianjin Cancer Institute,Tianjin Medical University
关键词
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
Background The prognosis for patients with gastric cancer and synchronous liver metastases is very poor.However,a standard therapeutic strategy has not been well established.The clinical benefit and prognostic factors after hepatic surgical treatment for liver metastases from gastric cancer remain controversial. Methods Records of 105 patients who underwent gastrectomy regardless of hepatic surgical treatment for gastric cancer with synchronous liver-only metastases in our center between 1995 and 2010 were retrospectively reviewed. Results The overall survival rate for the 105 patients was 42.1%,17.2%,and 10.6%at 1,2,and 3 years,respectively, with a median survival time of 11 months.Multivariate survival analysis revealed that the extent of lymphadenectomy(D) (P <0.001),lymph node metastases(P <0.001),extent of liver metastases(H)(P=0.008),and lymphovascular invasion (P=0.002) were significant independent prognostic factors for survival.Among patients who underwent D2 lymphadenectomy,those who underwent hepatic surgical treatment had a significantly improved survival compared with those who underwent gastrectomy alone(median survival,24 vs.12 months;P <0.001).However,hepatic surgical treatment was not a prognostic factor for patients who underwent D1 lymphadenectomy(median survival,8 vs.8 months; P=0.495).For the 35 patients who underwent gastrectomy plus hepatic surgical treatment,D2 lymphadenectomy(P <0.001),lymph node metastases(P=0.015),and extent of liver metastases(H1 vs.H2 and H3)(P=0.017) were independent significant prognostic factors for survival. Conclusions D2 lymphadenectomy plus hepatic surgical treatment may provide hope for long-term survival of judiciously selected patients with hepatic metastases from gastric cancer.Patients with a low degree of lymph node metastases and H1 liver metastases would make the most appropriate candidates.However,if D2 dissection cannot be achieved,hepatic surgical treatment is not recommended.
引用
收藏
页码:165 / 171
相关论文
共 50 条
  • [31] Prognostic Factors for Survival in Patients with Hepatic Recurrence After Curative Resection of Gastric Cancer
    Si-Eun Hwang
    Doo-Hyun Yang
    Chan-Young Kim
    World Journal of Surgery, 2009, 33 : 1468 - 1472
  • [32] Surgical resection of gastric cancer hepatic metastases: expanding the indications for curative treatment
    Markar, Sheraz R.
    Hanna, George B.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 1
  • [33] Long-term survival with stable disease after multidisciplinary treatment for synchronous liver metastases from gastric cancer: A case report
    Shi, Wenjun
    Wang, Junfeng
    Zhang, Wenjing
    Shou, Tao
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 65 : 317 - 321
  • [34] Surgical treatment of peritoneal metastases of gastric cancer
    Brandl, A.
    Pachmayr, E.
    Guel-Klein, S.
    Alberto, M.
    Thuss-Patience, P.
    Rau, B.
    CHIRURG, 2018, 89 (09): : 669 - 677
  • [35] Risk factors for liver metastases after curative surgical procedures for gastric cancer: A prospective study of 208 patients treated with surgical resection
    Marrelli, D
    Roviello, F
    De Stefano, A
    Fotia, G
    Giliberto, C
    Garosi, L
    Pinto, E
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (01) : 51 - 58
  • [36] Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study
    Jagric, Tomaz
    Horvat, Matjaz
    RADIOLOGY AND ONCOLOGY, 2021, 55 (01) : 57 - 65
  • [37] HEPATIC-ARTERY EMBOLIZATION IN THE TREATMENT OF GASTRIC-CANCER METASTASES TO THE LIVER
    TARAZOV, PG
    RYZHKOV, VK
    NOSKOV, AA
    KLINICHESKAYA MEDITSINA, 1988, 66 (12): : 84 - &
  • [38] Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection
    Jin Won Lee
    Moon Hyung Choi
    Young Joon Lee
    Bandar Ali
    Han Mo Yoo
    Kyo Young Song
    Cho Hyun Park
    BMC Cancer, 17
  • [39] VALUE OF LIVER FUNCTION TESTS IN DIAGNOSIS OF HEPATIC METASTASES IN PATIENTS WITH GASTRIC CANCER
    CEDERQVIST, C
    NIELSEN, J
    ACTA CHIRURGICA SCANDINAVICA, 1972, 138 (06): : 604 - +
  • [40] Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?
    Garancini, Mattia
    Uggeri, Fabio
    Degrate, Luca
    Nespoli, Luca
    Gianotti, Luca
    Nespoli, Angelo
    Uggeri, Franco
    Romano, Fabrizio
    HPB, 2012, 14 (03) : 209 - 215